Showing results (1591-1600 of 1,599) with videos related to

Sort By:
Pageof 160
You have reached the last page of results.This site can display upto 1,599 results.
The Lancet. Planetary Health|April 5, 2024
Advancing disability-inclusive climate research and action, climate justice, and climate-resilient developmentPenelope J S Stein, Michael Ashley Stein, Nora Groce, et al.
Blood|October 7, 2020
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 studyEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.
JAMA Network Open|August 26, 2024
Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO StudyAlain H Litwin, Judith I Tsui, Moonseong Heo, et al.
Blood|December 17, 2019
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemiaGail J Roboz, Courtney D DiNardo, Eytan M Stein, et al.
The New England Journal of Medicine|June 5, 2018
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AMLCourtney D DiNardo, Eytan M Stein, Stéphane de Botton, et al.
Blood|November 18, 2022
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of needNaveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, et al.
Ebiomedicine|November 28, 2021
Characterizing Long COVID: Deep Phenotype of a Complex ConditionRachel R Deer, Madeline A Rock, Nicole Vasilevsky, et al.
Laryngoscope Investigative Otolaryngology|September 25, 2025
Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional StudyMirabelle Sajisevi, Kenny Nguyen, Peter Callas, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 14, 2023
Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland CarcinomaMirabelle Sajisevi, Kenny Nguyen, Peter Callas, et al.
Pageof 160